Thursday , June 4 2020
Home / Tag Archives: reddy

Tag Archives: reddy

German regulator concludes audit of Dr Reddy’s Vishakapatnam facility

The Regulatory Authority of Germany (Regierung von Oberbayern) has concluded the follow-on audit of Dr. Reddy’s Laboratories’ Formulations manufacturing facility in Duvvada, Vishakapatnam, on November 09, 2018. The facility is considered compliant and the EU-GMP certification continues to remain active with one specific exclusion of a new product. The company ... Read More »

Dr. Reddy’s Lab launches Atomoxetine Capsules in US market

Dr. Reddy’s Laboratories has launched Atomoxetine Capsules, USP, a therapeutic equivalent generic version of Strattera (atomoxetine) Capsules in the United States market approved by the US Food and Drug Administration (USFDA). The Strattera brand and generic had US sales of approximately $304 million MAT for the most recent twelve months ... Read More »

Dr. Reddy’s Lab launches Colesevelam HCI Tablets

Dr. Reddy’s Laboratories has launched Colesevelam HCI Tablets, USP, a therapeutic equivalent generic version of WELCHOL (colesevelam HCI) Tablets in the United States market approved by the US Food and Drug Administration (USFDA). The WELCHOL brand and generic had US sales of around $471 million MAT for the most recent ... Read More »